These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34511668)

  • 1. Kindness is rewarded! The impact of corporate social responsibility on Chinese market reactions to the COVID-19 pandemic.
    Yi Y; Zhang Z; Yan Y
    Econ Lett; 2021 Nov; 208():110066. PubMed ID: 34511668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of COVID-19 on the Stock Price of Socially Responsible Enterprises: An Empirical Study in Taiwan Stock Market.
    Lee KJ; Lu SL
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33546396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Outbreak and Financial Performance of Chinese Listed Firms: Evidence From Corporate Culture and Corporate Social Responsibility.
    Sun Y; Li Y
    Front Public Health; 2021; 9():710743. PubMed ID: 34604155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Corporate Social Responsibility Efficiency in Chinese Food Industry Brought by COVID-19 Pandemic-A Study With the Super-Efficiency DEA-Malmquist-Tobit Model.
    Chen Z; Zhu W; Feng H; Luo H
    Front Public Health; 2022; 10():875030. PubMed ID: 35615039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Corporate Social Responsibility on Sustainable Innovation: A Case in China's Heavy Pollution Industry.
    Yan R; Li X; Zhu X
    Front Psychol; 2022; 13():946570. PubMed ID: 35859842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smog, media attention, and corporate social responsibility-empirical evidence from Chinese polluting listed companies.
    Xiong G; Luo Y
    Environ Sci Pollut Res Int; 2021 Sep; 28(34):46116-46129. PubMed ID: 33410010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The philanthropic response of substantive and symbolic corporate social responsibility strategies to COVID-19 crisis: Evidence from China.
    Zhong M; Zhao W; Shahab Y
    Corp Soc Responsib Environ Manag; 2022 Mar; 29(2):339-355. PubMed ID: 35465450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Financial Redundancy on Corporate Social Responsibility Performance: Evidence From Chinese Listed Firms.
    He L; Gan S; Zhong T
    Front Psychol; 2022; 13():882731. PubMed ID: 35664182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How High-Polluting Firms Suffer from Being Distracted form Intended Purpose: A Corporate Social Responsibility Perspective.
    Zhao XZ; Chen J; Chen FW; Wang W; Xia S
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33317027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does CSR performance improve corporate immunity to the COVID-19 pandemic? Evidence from China's stock market.
    Tian J; Wang X; Wei Y
    Front Public Health; 2022; 10():956521. PubMed ID: 36052006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Mandatory Disclosure Policies Promote Corporate Environmental Responsibility?-Quasi-Natural Experimental Research on China.
    Liu Y; Failler P; Chen L
    Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34205230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financial performance of China's listed firms in presence of coronavirus: Evidence from corporate culture and corporate social responsibility.
    Zheng F; Zhao Z; Sun Y; Khan YA
    Curr Psychol; 2023; 42(11):8897-8918. PubMed ID: 34400856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Returnee Executives, Corporate Social Responsibility, and Stock Price Synchronicity.
    Gao D; Zhao Y; Tian Q
    Front Psychol; 2022; 13():950436. PubMed ID: 35911051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corporate social responsibility budgeting and spending during COVID-19 in Oman: A humanitarian response to the pandemic.
    Baatwah SR; Al-Qadasi AA; Al-Shehri AM; Derouiche I
    Financ Res Lett; 2022 Jun; 47():102686. PubMed ID: 35035308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of COVID-19 on stock price crash risk: Evidence from Chinese energy firms.
    Huang S; Liu H
    Energy Econ; 2021 Sep; 101():105431. PubMed ID: 34876761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantity, Quality, and Performance of Corporate Social Responsibility Information Disclosure by Listed Enterprises in China: A Regional Perspective.
    Zhang H; Zhang Z; Tan A; Steklova E
    Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32230705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond COVID-19 Pandemic: An Integrative Review of Global Health Crisis Influencing the Evolution and Practice of Corporate Social Responsibility.
    Asante Antwi H; Zhou L; Xu X; Mustafa T
    Healthcare (Basel); 2021 Apr; 9(4):. PubMed ID: 33921512
    [No Abstract]   [Full Text] [Related]  

  • 18. Can corporate social responsibility protect firm value during the COVID-19 pandemic?
    Qiu SC; Jiang J; Liu X; Chen MH; Yuan X
    Int J Hosp Manag; 2021 Feb; 93():102759. PubMed ID: 36919172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perception of Corporate Hypocrisy in China: The Roles of Corporate Social Responsibility Implementation and Communication.
    Zhao Y; Qin Y; Zhao X; Wang X; Shi L
    Front Psychol; 2020; 11():595. PubMed ID: 32425840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does managerial short-termism always matter in a firm's corporate social responsibility performance? Evidence from China.
    Xu X; Yang J
    Heliyon; 2023 Mar; 9(3):e14240. PubMed ID: 36950626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.